Sirolimus-Eluting Stent
Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
... a sirolimus-eluting stent was implanted on the culprit left anterior descending coronary artery at primary percutaneous coronary intervention (PCI) for acute myocardial ...late stent ...
5
Clinical Performance of the Cobalt Chromium Biodegradable Polymer Coated Sirolimus Eluting Stent in an Unselected Real World Population
... its stent platform which is coated with a biodegradable polymer to deliver ...® stent system proved its effectiveness by reducing restenosis at 8 months and safety with an acceptable rate of cardiac events ...
10
Original Article The overlap nano-porous polymer-free sirolimus-eluting stent in swine model evaluated by optical coherence tomography and histopathology
... and stent was measured every 1 mm. Lumen area, stent area, neointi- mal area (stent area minus lumen area), the percent of neointimal area (ratio of neointimal area and stent area, multiplied ...
8
Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine
... Although animal model of restenosis has been widely used to evaluate the safety and efficacy of coronary stents, the accuracy of reflecting the human coronary artery response to such stents is still unclear. STZ was used ...
7
Original Article Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation
... polymer-free sirolimus-eluting stents were randomly implanted into coronary arteries of 8 normal ...after stent placement. For quantitative measures, lumen area, stent area, neointimal area ...
8
Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus Eluting Stent versus Paclitaxel Eluting Stent
... SE was defined as minimum stent diameter divided by maximum stent diameter. We investigated three different SE parameters defined as follows: 1) SE determined at the lesion site with maximal %NIH area on ...
9
Long-term effectiveness and safety of sirolimus drug-eluting stents
... After stent placement, platelet activation is usually reduced by the use of two platelet inhibitors with differing modes of action (aspirin and ...drug-eluting stent implantation should be the ...
8
Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus eluting stents and Resolute Integrity zotarolimus eluting stents in all comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial
... Hybrid sirolimus-eluting stent is a newly developed third-generation drug-eluting stent, featuring a unique dual-polymer ...drug, sirolimus, via controlled release, while a ...
6
Pharmacoeconomical comparison of bare metal stent and drug eluting stent
... Coronary Stent) in April 2002, a more powerful prevention of restenosis became commercially available in Europe and soon thereafter, in the United States and ...drug- eluting stents were developed and ...
9
Worsening Clinical Outcome with Increasing Number of So Called Off Label or Unapproved Indications for Use of Drug Eluting Stents
... the sirolimus eluting stent to be significantly better than the paclitaxel elut- ing stent ...The sirolimus-eluting stent in our study was slightly superior with a ...
11
Giant Coronary Artery Pseudoaneurysm after Drug Eluting Stent Implantation
... Formation of coronary artery pseudoaneurysm after percutaneous coronary intervention is rarely reported. A close review of available literature indicates a trend of growing incidence in recent times. Here, we present a ...
7
Polymer-free sirolimus-eluting stents in a large-scale all-comers population
... Colombo et al 15 conducted a single-armed study in an Italian all-comers population which demonstrated similar efficacy of a polymer-free sirolimus-eluting stent by usin- gorganic acids to modulate ...
10
Everolimus-eluting stents in interventional cardiology
... the sirolimus-eluting stent was superior to the paclitaxel-eluting stent for prevention of resteno- sis, the study was designed to assess noninferiority of the ...
13
Original Article A real world analysis of the angiographic patterns of in-stent restenosis and clinical outcome of second drug-eluting stent implantation
... Cypher sirolimus-eluting stent, 10 pa- tients ...paclitaxel-eluting stent, 8 (15.4%) received Firebird sirolimus-elu- ting and 7 patients ...ing stent placement to second ...
6
Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center
... and sirolimus-eluting stent groups, respec- tively (P = ...paclitaxel-eluting stent in the randomized ENDEAVOR IV ...paclitaxel-eluting stent at the 12-month follow-up, ...
7
Efficacies of the new Paclitaxel eluting Coroflex Please™ Stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please™ and Taxus™ (ECO PLEASANT) trial: study rationale and design
... the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions: A randomized comparison of a sirolimus eluting stent ...
9
Advances in coronary stent technology: current expectations and new developments
... More recently, fully biodegradable polymer coatings have been developed. These afford drug delivery through loading and elution of a lipophilic drug from a biocompat- ible polymer (to prevent restenosis early poststent ...
12
The benefits of drug-eluting stents in the treatment of coronary artery disease
... the stent to reduce the neointimal proliferation, thus resulting in the reduction of the rates of in-stent ...including stent thrombosis and delayed endothelialization of the stent ...
17
COMPARATIVE EVALUATION OF STAINLESS STEEL STENT (SIROLIMUS) AND COBALT CHROMIUM STENT (SIROLIMUS) IN PATIENT WITH CORONARY ARTERY DISEASE
... Primary end points of the present study were rate of target lesion revascularization, target vessel revascularization and restenosis, which were statistically insignificant in both the groups at 1 month, 6 months and 1 ...
5
One Year Clinical Outcomes of Biodegradable Polymer Coated Sirolimus Eluting Coronary Stent System in Patients with Coronary Artery Disease
... The most important observations of this single-center, observational study is: 1) 100% procedural success rate; 2) A low rates of MACE (1.6%) and ST (0.4%) at one-year follow-up. At one-year, the primary endpoint (MACE) ...
10